Clinical Trial Update: Vvax001 Cancer Vaccine in (Pre) Malignant Cervical Lesions [Phase 1]

View source ↗

Summary

Phase 1 study update on the Vvax001 cancer vaccine targeting cervical lesions, including CIN 2/3 and cervical cancer, with the trial status marked as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia 3

Drugs mentioned

• Vvax001 Cancer Vaccine

Snippet

Sponsor: University Medical Center Groningen | Conditions: CIN 2/3, Cervical Cancer | Phase 1 | Status: COMPLETED